div class=ts-pagebuttonPage 1button div class=ts-image amp-img class=ts-thumb alt=Page 1: privind riscul de aparitie a · ndicaÿi lor terapeutice aprobate si anume utilizarea la pacienÿii cu diabet zaharat e tip 1 Pe aceasti cale ge reaxninte}te medicilor prescriptori src=https:reader033vdocumentecomreader033viewer20220416125e3869344395e5138660a282html5thumbnails1jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 2button div class=ts-image amp-img class=ts-thumb alt=Page 2: privind riscul de aparitie a · ndicaÿi lor terapeutice aprobate si anume utilizarea la pacienÿii cu diabet zaharat e tip 1 Pe aceasti cale ge reaxninte}te medicilor prescriptori src=https:reader033vdocumentecomreader033viewer20220416125e3869344395e5138660a282html5thumbnails2jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 3button div class=ts-image amp-img class=ts-thumb alt=Page 3: privind riscul de aparitie a · ndicaÿi lor terapeutice aprobate si anume utilizarea la pacienÿii cu diabet zaharat e tip 1 Pe aceasti cale ge reaxninte}te medicilor prescriptori src=https:reader033vdocumentecomreader033viewer20220416125e3869344395e5138660a282html5thumbnails3jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 4button div class=ts-image amp-img class=ts-thumb alt=Page 4: privind riscul de aparitie a · ndicaÿi lor terapeutice aprobate si anume utilizarea la pacienÿii cu diabet zaharat e tip 1 Pe aceasti cale ge reaxninte}te medicilor prescriptori src=https:reader033vdocumentecomreader033viewer20220416125e3869344395e5138660a282html5thumbnails4jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 5button div class=ts-image amp-img class=ts-thumb alt=Page 5: privind riscul de aparitie a · ndicaÿi lor terapeutice aprobate si anume utilizarea la pacienÿii cu diabet zaharat e tip 1 Pe aceasti cale ge reaxninte}te medicilor prescriptori src=https:reader033vdocumentecomreader033viewer20220416125e3869344395e5138660a282html5thumbnails5jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 6button div class=ts-image amp-img class=ts-thumb alt=Page 6: privind riscul de aparitie a · ndicaÿi lor terapeutice aprobate si anume utilizarea la pacienÿii cu diabet zaharat e tip 1 Pe aceasti cale ge reaxninte}te medicilor prescriptori src=https:reader033vdocumentecomreader033viewer20220416125e3869344395e5138660a282html5thumbnails6jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 7button div class=ts-image amp-img class=ts-thumb alt=Page 7: privind riscul de aparitie a · ndicaÿi lor terapeutice aprobate si anume utilizarea la pacienÿii cu diabet zaharat e tip 1 Pe aceasti cale ge reaxninte}te medicilor prescriptori src=https:reader033vdocumentecomreader033viewer20220416125e3869344395e5138660a282html5thumbnails7jpg width=142 height=106 layout=responsive amp-img divdiv